Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Meijer

Showing results (41-50 of 97) with videos related to

Pageof 10
Sort By:
International Journal of Laboratory Hematology|June 8, 2023
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitorsPiet Meijer, Flora Peyvandi, Guy Young, et al.
Clinical Chemistry|June 29, 2002
Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombinPiet Meijer, Moniek P M de Maat, Cornelis Kluft, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2026
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devicesSandya Arunachalam, Tony Badrick, Emmanuel J Favaloro, et al.
BMC Cardiovascular Disorders|June 7, 2002
Diagnostic strategies for C-reactive proteinHarriëtte Riese, Tanja G M Vrijkotte, Piet Meijer, et al.
Seminars in Thrombosis and Hemostasis|February 6, 2014
Proficiency testing results for heparin-induced thrombocytopenia in north americaKristi J Smock, Marlies R Ledford-Kraemer, Piet Meijer, et al.
American Journal of Hematology|July 27, 2016
Testing for dabigatran and rivaroxaban by clinical laboratoriesElizabeth M Van Cott, Kristi J Smock, Dong Chen, et al.
Clinical Chemistry|September 29, 2016
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance SpecificationsMoniek P M de Maat, Marianne van Schie, Cornelis Kluft, et al.
American Journal of Clinical Pathology|March 18, 2009
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experienceEllinor I B Peerschke, Donna D Castellone, Marlies Ledford-Kraemer, et al.
Clinical Chemistry and Laboratory Medicine|February 20, 2025
Short-term biological variation of coagulation and fibrinolytic measurandsMartine J Hollestelle, Ann Helen Kristoffersen, René N Idema, et al.
International Journal of Laboratory Hematology|January 14, 2026
Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment ProgrammesAnna Williams, Piet Meijer, Elysse Dean, et al.
Pageof 10

Showing results (41-50 of 97) with videos related to

Sort By:
Pageof 10
International Journal of Laboratory Hematology|June 8, 2023
International Council for Standardization in Haematology recommendations for laboratory measurement of factor VIII and FIX type I inhibitorsPiet Meijer, Flora Peyvandi, Guy Young, et al.
Clinical Chemistry|June 29, 2002
Long-term analytical performance of hemostasis field methods as assessed by evaluation of the results of an external quality assessment program for antithrombinPiet Meijer, Moniek P M de Maat, Cornelis Kluft, et al.
Clinical Chemistry and Laboratory Medicine|July 9, 2026
Systematic bias in point-of-care INR testing: comparative analysis of Abbott and Roche devicesSandya Arunachalam, Tony Badrick, Emmanuel J Favaloro, et al.
BMC Cardiovascular Disorders|June 7, 2002
Diagnostic strategies for C-reactive proteinHarriëtte Riese, Tanja G M Vrijkotte, Piet Meijer, et al.
Seminars in Thrombosis and Hemostasis|February 6, 2014
Proficiency testing results for heparin-induced thrombocytopenia in north americaKristi J Smock, Marlies R Ledford-Kraemer, Piet Meijer, et al.
American Journal of Hematology|July 27, 2016
Testing for dabigatran and rivaroxaban by clinical laboratoriesElizabeth M Van Cott, Kristi J Smock, Dong Chen, et al.
Clinical Chemistry|September 29, 2016
Biological Variation of Hemostasis Variables in Thrombosis and Bleeding: Consequences for Performance SpecificationsMoniek P M de Maat, Marianne van Schie, Cornelis Kluft, et al.
American Journal of Clinical Pathology|March 18, 2009
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experienceEllinor I B Peerschke, Donna D Castellone, Marlies Ledford-Kraemer, et al.
Clinical Chemistry and Laboratory Medicine|February 20, 2025
Short-term biological variation of coagulation and fibrinolytic measurandsMartine J Hollestelle, Ann Helen Kristoffersen, René N Idema, et al.
International Journal of Laboratory Hematology|January 14, 2026
Performance of Factor VIII Extended Half-Life Product Measurements in External Quality Assessment ProgrammesAnna Williams, Piet Meijer, Elysse Dean, et al.
Pageof 10